Topotecan in mantle cell lymphoma - A 21 day continuous infusion regimen may have advantages over intermittent therapy.

Παρόμοια τεκμήρια

• Weekly topotecan regimen in the treatment of recurrent ovarian cancer: search for alternatives to upholding the quality of life
  ανά: E. G. Novikova, κ.ά.
  Έκδοση: (2014-08-01)
• Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
  ανά: Enver Aydilek, κ.ά.
  Έκδοση: (2023-09-01)
• The role of topotecan in cancer ginecology treatment
  ανά: A. G. Kedrova, κ.ά.
  Έκδοση: (2017-02-01)
• Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
  ανά: E. G. Novikova, κ.ά.
  Έκδοση: (2014-07-01)
• The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
  ανά: K. E. Borisov
  Έκδοση: (2014-07-01)